Toolkit/two-input protein logic OR gate

two-input protein logic OR gate

Multi-Component Switch·Research·Since 2021

Also known as: engineered, single protein design, two-input logic OR gate

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The two-input protein logic OR gate is an engineered single-protein focal adhesion kinase (FAK) system designed to integrate chemical and optical inputs within the native FAK domain architecture. It functions as an allosterically regulated OR gate by combining a rapamycin-inducible uniRapR module in the kinase domain with a light-inducible LOV2 module in the FERM domain.

Usefulness & Problems

Why this is useful

This tool is useful for implementing protein-level computation in living cells using orthogonal chemo-optogenetic control. In the reported system, dynamic FAK activation altered cell behavior in a fibrous extracellular matrix microenvironment, increasing multiaxial complexity and decreasing motility.

Problem solved

It addresses the problem of integrating two distinct external inputs into a single engineered signaling protein while retaining the underlying FAK domain architecture. The reported design specifically enables OR-gate control of FAK activity through chemical and optical regulation.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Target processes

No target processes tagged yet.

Implementation Constraints

The reported construct places a rapamycin-inducible uniRapR module in the FAK kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture. Practical implementation therefore requires rapamycin as the chemical input and optical stimulation of the LOV2-containing module, but the supplied evidence does not specify expression system details or illumination parameters.

The supplied evidence is limited to a single 2021 source and does not provide quantitative performance metrics such as activation dynamic range, response kinetics, leakiness, or reversibility. Evidence for validation across multiple cell types, organisms, or independent studies is not provided.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 2cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 3cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 4cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 5cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 6cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 7cellular effectsupports2021Source 1needs review

Dynamic FAK activation increased cell multiaxial complexity in a fibrous extracellular matrix microenvironment and decreased cell motility.

We demonstrate that dynamic FAK activation profoundly increased cell multiaxial complexity in the fibrous extracellular matrix microenvironment and decreased cell motility.
Claim 8design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 9design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 10design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 11design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 12design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 13design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 14design architecturesupports2021Source 1needs review

The engineered focal adhesion kinase system uses chemo- and optogenetic regulation with a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain while retaining FAK domain architecture.

Our system is based on chemo- and optogenetic regulation of focal adhesion kinase. In the engineered FAK, all of FAK domain architecture is retained and key intramolecular interactions between the kinase and the FERM domains are externally controlled through a rapamycin-inducible uniRapR module in the kinase domain and a light-inducible LOV2 module in the FERM domain.
Claim 15engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 16engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 17engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 18engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 19engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 20engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 21engineered functionsupports2021Source 1needs review

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'
Claim 22orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 23orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 24orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 25orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 26orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 27orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 28orthogonal regulationsupports2021Source 1needs review

Chemo- and optogenetic switches enabled orthogonal regulation of protein function in the engineered system.

Orthogonal regulation of protein function was possible using the chemo- and optogenetic switches.
Claim 29proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 30proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 31proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 32proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 33proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 34proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function
Claim 35proof of principlesupports2021Source 1needs review

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function

Approval Evidence

1 source2 linked approval claimsfirst-pass slug two-input-protein-logic-or-gate
we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'

Source:

engineered functionsupports

An engineered single protein design was allosterically regulated to function as a two-input logic OR gate.

we report an engineered, single protein design that is allosterically regulated to function as a 'two-input logic OR gate'

Source:

proof of principlesupports

The work provides proof-of-principle for fine multimodal control of protein function.

This work provides proof-of-principle for fine multimodal control of protein function

Source:

Comparisons

Source-backed strengths

The design embeds both rapamycin-inducible and light-inducible control modules in a single FAK protein and was reported to operate as a two-input logic OR gate. It was also linked to measurable cellular effects, with dynamic FAK activation increasing cell multiaxial complexity and decreasing motility in a fibrous extracellular matrix setting.

Ranked Citations

  1. 1.
    StructuralSource 1Nature Communications2021Claim 1Claim 2Claim 3

    Extracted from this source document.